SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-034052
Filing Date
2022-06-22
Accepted
2022-06-21 18:45:14
Documents
13
Period of Report
2022-06-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161879-8k_inmedpharma.htm   iXBRL 8-K 29157
  Complete submission text file 0001213900-22-034052.txt   241515

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE inm-20220617.xsd EX-101.SCH 3202
3 XBRL DEFINITION FILE inm-20220617_def.xml EX-101.DEF 26195
4 XBRL LABEL FILE inm-20220617_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE inm-20220617_pre.xml EX-101.PRE 24853
7 EXTRACTED XBRL INSTANCE DOCUMENT ea161879-8k_inmedpharma_htm.xml XML 4179
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221029485
SIC: 2834 Pharmaceutical Preparations